LHX vs TTRX · P/E 34, rev $5.88B vs $187.1M cap
L3Harris Technologies Inc (LHX) versus Turn Therapeutics Inc. Common Stock (TTRX) — a side-by-side from cached financials, not a winner call.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
TTRX does not have a complete income-statement cache yet.
LHX currently screens at market cap $58.72B and trailing P/E 34.3. TTRX currently screens at market cap $187.1M.
Not investment advice. Open the LHX and TTRX stock pages for the full models.
Not investment advice.